MIME-Version: 1.0
Date: Fri, 3 Apr 2020 14:56:27 -0400
References: <000000000000a1716205a2674bcb@google.com>
	<FD3D9695-01B6-4505-8FE0-02DE3485E8E5@gmail.com>
	<CH2PR20MB30795668B6E5A2822F94F7C0B6C70@CH2PR20MB3079.namprd20.prod.outlook.com>
In-Reply-To: <CH2PR20MB30795668B6E5A2822F94F7C0B6C70@CH2PR20MB3079.namprd20.prod.outlook.com>
Message-ID: <CACNgykMexp9mLXG7NR3dK0hxpEARYD1g6JcLWKEzRqwyuE38zg@mail.gmail.com>
Subject: Fwd: My son's comment after todays discussion.
From: Josh Klein <josh@josh.is>
To: =?UTF-8?Q?Hulda_Emilsd=C3=B3ttir?= <hulda@simple.is>
Content-Type: multipart/alternative; boundary="0000000000008a237205a2677978"

--0000000000008a237205a2677978
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

FYI, this is Keith's analysis of what to look for as signs of recovery.

xoxo,
Josh


---------- Forwarded message ---------
From: Keith Watson <keith@practivistinvestors.com>
Date: Fri, Apr 3, 2020 at 2:53 PM
Subject: Re: My son's comment after todays discussion.
To: Rafe Furst <rafe.furst@gmail.com>, Daniel Horowitz <danielih@gmail.com>=
,
Jason McKinley <jasonmckinley@mac.com>, Josh Klein <josh@josh.is>


Here is the note I showed on the call:

I have been studying COVID-19 from all angles since early January and I
thought it might be useful to share my thoughts on what leaders of global
enterprises, like yourself, should be looking for in the coming weeks.

In my opinion, four important milestones will mark progress toward a return
to normalcy. These milestones are:


(1) A formal recommendation from the CDC that all Americans wear masks when
in public.

(2) The scientific validation of an effective and readily available oral
therapy that reduces disease severity.

(3) The scientific validation and widespread deployment of antibody testing
to identify who has already been infected with the disease and is therefore
likely immune without knowing it.

(4) The scientific validation, production, and widespread deployment of an
effective vaccine.


On the CDC and Masks


The US was, amazingly, caught flat-footed on COVID-19 despite months of
warning about what was occurring in China. In particular, US hospitals were
short on basic personal protective equipment like latex gloves and masks.
As a result, I believe the CDC was put in a difficult position. If they
recommended widespread use of masks to the public, they risked causing a
run on supplies similar to what was observed with toilet paper. If they
deemphasized the need for masks, they risked allowing the disease to spread
more rapidly. I believe the CDC is purposely downplaying the need for masks
until the hospital supply situation is resolved. I suspect that within a
week or so, the CDC will issue a widespread call for all Americans to use
masks while in public. This will signal two important things. First, it
will indicate that the hospital PPE situation is largely resolved. Second,
it will indicate the first steps toward lifting stay-at-home orders. To be
clear, I view a concerted public awareness campaign around masks to be the
first true sign that the peak may be behind us.


Oral Therapy


Both for the existing outbreak and the inevitable return of the disease
this fall (i.e., Wave II), the development of an effective oral therapy
that reduces disease severity will be a critical milestone. In particular,
a therapy that substantially eliminates the need for ventilators would mark
a real turning point disease management. There are several reports that the
use of hydroxychloroquine, either alone or in combination with the
antibiotic Zithromax, or even in combination with blood transfusions, is
effective for disease management. The data and data quality are quite mixed
at the moment, which is understandable given the fog of war involved on the
front lines. The full power of global pharmaceutical research is already
being deployed against this problem. A definitive FDA approval of an oral
therapy for disease management would be truly game-changing. At that point,
one could safely assume that worst-case scenario risks for Wave II are off
the table.


Antibody Testing


What if you already had COVID-19 but you did not know it because your
symptoms were mild and you recovered quickly? What if your body has already
developed some form of immunity to the disease, substantially reducing your
risk of re-infection? Knowing this information as an individual would be
very empowering. Knowing it more broadly across the population would
substantially aid in our ability to return to normalcy and, most
critically, facilitate a more targeted and effective response to Wave II.
Antibody blood tests have been used for decades in other disease-tracking
initiatives. There have been many press reports about new tests specific
for COVID-19. Once again, formal FDA approvals and CDC recommendations are
the key milestones to look for as a leader.


Widespread Vaccine Deployment


COVID-19 will only be defeated when an effective vaccine is developed and
widely available. Unfortunately, this simply takes time. Normally, it would
be considered heroic to invent and distribute an effective vaccine within
18 months. Based on the substantial scientific resources being deployed
against this problem, and the commitment of the FDA to accelerate approvals
and remove bureaucratic red tape, I feel it is possible that a vaccine can
be deployed in early 2021. Once a vaccine plan is approved and
communicated, we will finally be at the beginning of the end of the medical
aspects of our response.


Summary


I believe the four milestones outlined herein provide practical markers for
leaders to better understand where we are in the medical response to this
disease. The political and economic fallout from all of this are subjects
for future analysis. Hopefully this note was useful.


Best regards,

Keith



------------------------------
*From:* Rafe Furst <rafe.furst@gmail.com>
*Sent:* Friday, April 3, 2020 2:50 PM
*To:* Daniel Horowitz <danielih@gmail.com>; Jason McKinley <
jasonmckinley@mac.com>; Josh Klein <josh@josh.is>; Keith Watson <
keith@practivistinvestors.com>
*Subject:* Re: My son's comment after todays discussion.

Brilliant observations=E2=80=A6

BTW, Daniel and I stayed on a few minutes and talked about creating a Schel=
ling
Point <https://nav.al/schelling-point> for truth and truth tellers. The
Satoshi White Paper that launched Bitcoin and blockchain tech could be
considered a Schelling point for =E2=80=9Cdistributed immutable ledger of
transactions=E2=80=9D.

By focusing on truth and truth tellers (I like Seth Godin=E2=80=99s term sh=
ared
objective reality <https://seths.blog/2020/03/shared-objective-reality/> ra=
ther
than truth) this connects to Keith=E2=80=99s practice and belief in the pow=
er of
micro-influencers, but could potentially address the moral hazard that
Casey points out below=E2=80=A6

=E2=80=94Rafe

On Apr 3, 2020, at 12:43 PM, Jason McKinley <jason@crowdfunder.com> wrote:

Case note to Keith | From my son Casey
The idea of the influencer as an agent of significant change is promising,
but I have my doubts.

My (admittedly limited) observation of online influencers, and especially
those that capture the attention of young people, leads me to believe that
the same institutional bias toward bad action alive in the corporate space
exists for influencers.

Just as a C level position at a major company is dependent upon a
willingness to commit fraud influencership seems to be conditioned on sin.
The profitable sins for influencers being sensationalism, misinformation,
and appeals to negative emotion rather than fraud.
Kassandra, Nostradamus & Tony Robbins walk into a bar...

*When*
Fri Apr 3, 2020 7am =E2=80=93 8am Hawaii-Aleutian Standard Time

*Where*
https://zoom.us/j/5911291378 (map
<https://www.google.com/url?q=3Dhttps%3A%2F%2Fzoom.us%2Fj%2F5911291378&sa=
=3DD&ust=3D1586371417735000&usg=3DAFQjCNGgjZewgkYl0wbo9Lave51vmyGNig>
)

*Who*
=E2=80=A2
rafe.furst@gmail.com - organizer
=E2=80=A2
jasonmckinley@mac.com
=E2=80=A2
Josh Klein
=E2=80=A2
Daniel Horowitz
=E2=80=A2
Keith Watson
Rafe Furst is inviting you to a scheduled Zoom meeting.

Join Zoom Meeting

https://zoom.us/j/5911291378
<https://www.google.com/url?q=3Dhttps%3A%2F%2Fzoom.us%2Fj%2F5911291378&sa=
=3DD&ust=3D1586371417733000&usg=3DAFQjCNFvCUIrfLIlT9wxy1xrMlzvUSEDEg>

Meeting ID: 591 129 1378

One tap mobile

+13462487799,,5911291378# US (Houston)

+16699006833,,5911291378# US (San Jose)

Dial by your location

+1 346 248 7799 US (Houston)

+1 669 900 6833 US (San Jose)

+1 312 626 6799 US (Chicago)

+1 929 436 2866 US (New York)

+1 253 215 8782 US

+1 301 715 8592 US

Meeting ID: 591 129 1378

Find your local number: https://zoom.us/u/abnmCquRh7
<https://www.google.com/url?q=3Dhttps%3A%2F%2Fzoom.us%2Fu%2FabnmCquRh7&sa=
=3DD&ust=3D1586371417734000&usg=3DAFQjCNFlPY14TnV4rpDJtggEadWzjS9o8g>



=E1=90=A7

--0000000000008a237205a2677978
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">FYI, this is Keith&#39;s analysis of what to look for as s=
igns of recovery.<div><br></div><div>xoxo,<br>Josh</div><div><br><br><div c=
lass=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">---------- Forwa=
rded message ---------<br>From: <strong class=3D"gmail_sendername" dir=3D"a=
uto">Keith Watson</strong> <span dir=3D"auto">&lt;<a href=3D"mailto:keith@p=
ractivistinvestors.com">keith@practivistinvestors.com</a>&gt;</span><br>Dat=
e: Fri, Apr 3, 2020 at 2:53 PM<br>Subject: Re: My son&#39;s comment after t=
odays discussion.<br>To: Rafe Furst &lt;<a href=3D"mailto:rafe.furst@gmail.=
com">rafe.furst@gmail.com</a>&gt;, Daniel Horowitz &lt;<a href=3D"mailto:da=
nielih@gmail.com">danielih@gmail.com</a>&gt;, Jason McKinley &lt;<a href=3D=
"mailto:jasonmckinley@mac.com">jasonmckinley@mac.com</a>&gt;, Josh Klein &l=
t;<a href=3D"mailto:josh@josh.is">josh@josh.is</a>&gt;<br></div><br><br>




<div dir=3D"ltr">
<div style=3D"font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt=
;color:rgb(0,0,0)">
Here is the note I showed on the call:</div>
<div style=3D"font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt=
;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt=
;color:rgb(0,0,0)">
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">I have been studying COVID-19 from all angles since =
early January and I thought it might be useful to share my thoughts on what=
 leaders of global enterprises,
 like yourself, should be looking for in the coming weeks.</span><span styl=
e=3D"font-family:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">In my opinion, four important milestones will mark p=
rogress toward a return to normalcy. These milestones are:</span><span styl=
e=3D"font-family:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">(1) A formal recommendation from the CDC that all Am=
ericans wear masks when in public.</span><span style=3D"font-family:Calibri=
,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in">(2) The scientific validation of an effective =
and readily available oral therapy that reduces disease severity.</span></s=
pan><span style=3D"font-family:Calibri,sans-serif;color:rgb(32,31,30)"></sp=
an></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in">(3) The scientific validation and widespread d=
eployment of antibody testing to identify who has already been infected wit=
h the disease and is therefore
 likely immune without knowing it.</span></span><span style=3D"font-family:=
Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in">(4) The scientific validation, production, and=
 widespread deployment of an effective vaccine.=C2=A0</span></span><span st=
yle=3D"font-family:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in"><br>
</span></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">On the CDC and Masks</span><span style=3D"font-famil=
y:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">The US was, amazingly, caught flat-footed on COVID-1=
9 despite months of warning about what was occurring in China. In particula=
r, US hospitals were short
 on basic personal protective equipment like latex gloves and masks. As a r=
esult, I believe the CDC was put in a difficult position. If they recommend=
ed widespread use of masks to the public, they risked causing a run on supp=
lies similar to what was observed
 with toilet paper. If they deemphasized the need for masks, they risked al=
lowing the disease to spread more rapidly. I believe the CDC is purposely d=
ownplaying the need for masks until the hospital supply situation is resolv=
ed. I suspect that within a week
 or so, the CDC will issue a widespread call for all Americans to use masks=
 while in public. This will signal two important things. First, it will ind=
icate that the hospital PPE situation is largely resolved. Second, it will =
indicate the first steps toward
 lifting stay-at-home orders. To be clear, I view a concerted public awaren=
ess campaign around masks to be the first true sign that the peak may be be=
hind us.=C2=A0</span><span style=3D"font-family:Calibri,sans-serif;color:rg=
b(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">Oral Therapy</span><span style=3D"font-family:Calibr=
i,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">Both for the existing outbreak and the inevitable re=
turn of the disease this fall (i.e., Wave II), the development of an effect=
ive oral therapy that reduces
 disease severity will be a critical milestone. In particular, a therapy th=
at substantially eliminates the need for ventilators would mark a real turn=
ing point disease management. There are several reports that the use of hyd=
roxychloroquine, either alone or
 in combination with the antibiotic Zithromax, or even in combination with =
blood transfusions, is effective for disease management. The data and data =
quality are quite mixed at the moment, which is understandable given the fo=
g of war involved on the front lines.
 The full power of global pharmaceutical research is already being deployed=
 against this problem. A definitive FDA approval of an oral therapy for dis=
ease management would be truly game-changing. At that point, one could safe=
ly assume that worst-case scenario
 risks for Wave II are off the table.=C2=A0</span><span style=3D"font-famil=
y:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">Antibody Testing</span><span style=3D"font-family:Ca=
libri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">What if you already had COVID-19 but you did not kno=
w it because your symptoms were mild and you recovered quickly? What if you=
r body has already developed
 some form of immunity to the disease, substantially reducing your risk of =
re-infection? Knowing this information as an individual would be very empow=
ering. Knowing it more broadly across the population would substantially ai=
d in our ability to return to normalcy
 and, most critically, facilitate a more targeted and effective response to=
 Wave II. Antibody blood tests have been used for decades in other disease-=
tracking initiatives. There have been many press reports about new tests sp=
ecific for COVID-19. Once again,
 formal FDA approvals and CDC recommendations are the key milestones to loo=
k for as a leader.</span><span style=3D"font-family:Calibri,sans-serif;colo=
r:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">Widespread Vaccine Deployment</span><span style=3D"f=
ont-family:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">COVID-19 will only be defeated when an effective vac=
cine is developed and widely available. Unfortunately, this simply takes ti=
me. Normally, it would be
 considered heroic to invent and distribute an effective vaccine within 18 =
months. Based on the substantial scientific resources being deployed agains=
t this problem, and the commitment of the FDA to accelerate approvals and r=
emove bureaucratic red tape, I feel
 it is possible that a vaccine can be deployed in early 2021. Once a vaccin=
e plan is approved and communicated, we will finally be at the beginning of=
 the end of the medical aspects of our response.=C2=A0</span><span style=3D=
"font-family:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">Summary</span><span style=3D"font-family:Calibri,san=
s-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in"><br>
</span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in">I believe the four milestones outlined herein =
provide practical markers for leaders to better understand where we are in =
the medical response to this
 disease. The political and economic fallout from all of this are subjects =
for future analysis. Hopefully this note was useful.</span><span style=3D"f=
ont-family:Calibri,sans-serif;color:rgb(32,31,30)"></span></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in"><br>
</span></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt none w=
indowtext;padding:0in">Best regards,</span><span style=3D"font-family:Calib=
ri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin-right:0in;margin-left:0in;font-size:medium;font-family:&=
quot;Times New Roman&quot;,serif">
<span><span style=3D"font-family:Calibri,sans-serif;color:black;border:1pt =
none windowtext;padding:0in">Keith=C2=A0</span></span><span style=3D"font-f=
amily:Calibri,sans-serif;color:rgb(32,31,30)"></span></p>
<p style=3D"margin:0in 0in 0.0001pt;font-size:medium;font-family:Calibri,sa=
ns-serif">
<span><u></u>=C2=A0<u></u></span></p>
<br>
</div>
<div id=3D"m_-7238727578274140814appendonsend"></div>
<hr style=3D"display:inline-block;width:98%">
<div id=3D"m_-7238727578274140814divRplyFwdMsg" dir=3D"ltr"><font face=3D"C=
alibri, sans-serif" style=3D"font-size:11pt" color=3D"#000000"><b>From:</b>=
 Rafe Furst &lt;<a href=3D"mailto:rafe.furst@gmail.com" target=3D"_blank">r=
afe.furst@gmail.com</a>&gt;<br>
<b>Sent:</b> Friday, April 3, 2020 2:50 PM<br>
<b>To:</b> Daniel Horowitz &lt;<a href=3D"mailto:danielih@gmail.com" target=
=3D"_blank">danielih@gmail.com</a>&gt;; Jason McKinley &lt;<a href=3D"mailt=
o:jasonmckinley@mac.com" target=3D"_blank">jasonmckinley@mac.com</a>&gt;; J=
osh Klein &lt;<a href=3D"mailto:josh@josh.is" target=3D"_blank">josh@josh.i=
s</a>&gt;; Keith Watson &lt;<a href=3D"mailto:keith@practivistinvestors.com=
" target=3D"_blank">keith@practivistinvestors.com</a>&gt;<br>
<b>Subject:</b> Re: My son&#39;s comment after todays discussion.</font>
<div>=C2=A0</div>
</div>
<div style=3D"word-wrap:break-word;line-break:after-white-space">Brilliant =
observations=E2=80=A6
<div><br>
</div>
<div>BTW, Daniel and I stayed on a few minutes and talked about creating a=
=C2=A0<a href=3D"https://nav.al/schelling-point" target=3D"_blank">Schellin=
g Point</a>=C2=A0for truth and truth tellers. The Satoshi White Paper that =
launched Bitcoin and blockchain tech could be
 considered a Schelling point for =E2=80=9Cdistributed immutable ledger of =
transactions=E2=80=9D.</div>
<div><br>
</div>
<div>By focusing on truth and truth tellers (I like Seth Godin=E2=80=99s te=
rm=C2=A0<a href=3D"https://seths.blog/2020/03/shared-objective-reality/" ta=
rget=3D"_blank">shared objective reality</a>=C2=A0rather than truth) this c=
onnects to Keith=E2=80=99s practice and belief in the power
 of micro-influencers, but could potentially address the moral hazard that =
Casey points out below=E2=80=A6</div>
<div><br>
</div>
<div>=E2=80=94Rafe<br>
<div><br>
<blockquote type=3D"cite">
<div>On Apr 3, 2020, at 12:43 PM, Jason McKinley &lt;<a href=3D"mailto:jaso=
n@crowdfunder.com" target=3D"_blank">jason@crowdfunder.com</a>&gt; wrote:</=
div>
<br>
<div><span>
<p>Case note to Keith | From my son Casey<br>
The idea of the influencer as an agent of significant change is promising, =
but I have my doubts.</p>
<p>My (admittedly limited) observation of online influencers, and especiall=
y those that capture the attention of young people, leads me to believe tha=
t the same institutional bias toward bad action alive in the corporate spac=
e exists for influencers.</p>
<p>Just as a C level position at a major company is dependent upon a willin=
gness to commit fraud influencership seems to be conditioned on sin. The pr=
ofitable sins for influencers being sensationalism, misinformation, and app=
eals to negative emotion
 rather than fraud.</p>
</span><span><span style=3D"display:none">

</span><span>
<div>
<table cellspacing=3D"0" cellpadding=3D"8" border=3D"0" summary=3D"" style=
=3D"width:100%;font-family:Arial,Sans-serif;border:1px Solid #ccc;border-wi=
dth:1px 2px 2px 1px;background-color:#fff">
<tbody>
<tr>
<td>

<div style=3D"padding:2px"><span>

</span>

<h3 style=3D"padding:0 0 6px 0;margin:0;font-family:Arial,Sans-serif;font-s=
ize:16px;font-weight:bold;color:#222">
<span>Kassandra, Nostradamus &amp; Tony Robbins walk into a bar...</span></=
h3>
<table cellpadding=3D"0" cellspacing=3D"0" border=3D"0" summary=3D"Event de=
tails" style=3D"display:inline-table">
<tbody>
<tr>
<td valign=3D"top" style=3D"padding:0 1em 10px 0;font-family:Arial,Sans-ser=
if;font-size:13px;color:#888;white-space:nowrap">
<div><i style=3D"font-style:normal">When</i></div>
</td>
<td valign=3D"top" style=3D"padding-bottom:10px;font-family:Arial,Sans-seri=
f;font-size:13px;color:#222">
Fri Apr 3, 2020 7am =E2=80=93 8am
<span style=3D"color:#888">Hawaii-Aleutian Standard Time</span></td>
</tr>
<tr>
<td valign=3D"top" style=3D"padding:0 1em 10px 0;font-family:Arial,Sans-ser=
if;font-size:13px;color:#888;white-space:nowrap">
<div><i style=3D"font-style:normal">Where</i></div>
</td>
<td valign=3D"top" style=3D"padding-bottom:10px;font-family:Arial,Sans-seri=
f;font-size:13px;color:#222">
<span><span><a href=3D"https://zoom.us/j/5911291378" target=3D"_blank">http=
s://zoom.us/j/5911291378</a></span><span dir=3D"ltr"> (<a href=3D"https://w=
ww.google.com/url?q=3Dhttps%3A%2F%2Fzoom.us%2Fj%2F5911291378&amp;sa=3DD&amp=
;ust=3D1586371417735000&amp;usg=3DAFQjCNGgjZewgkYl0wbo9Lave51vmyGNig" style=
=3D"color:#20c;white-space:nowrap" target=3D"_blank">map</a>)</span></span>=
</td>
</tr>
<tr>
<td valign=3D"top" style=3D"padding:0 1em 10px 0;font-family:Arial,Sans-ser=
if;font-size:13px;color:#888;white-space:nowrap">
<div><i style=3D"font-style:normal">Who</i></div>
</td>
<td valign=3D"top" style=3D"padding-bottom:10px;font-family:Arial,Sans-seri=
f;font-size:13px;color:#222">
<table cellspacing=3D"0" cellpadding=3D"0">
<tbody>
<tr>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<span style=3D"font-family:Courier New,monospace">=E2=80=A2</span></td>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<div>
<div style=3D"margin:0 0 0.3em 0"><span><span><a href=3D"mailto:rafe.furst@=
gmail.com" target=3D"_blank">rafe.furst@gmail.com</a></span>

 </span><span>


</span><span style=3D"font-size:11px;color:#888">- organizer</span></div>
</div>
</td>
</tr>
<tr>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<span style=3D"font-family:Courier New,monospace">=E2=80=A2</span></td>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<div>
<div style=3D"margin:0 0 0.3em 0"><span><span><a href=3D"mailto:jasonmckinl=
ey@mac.com" target=3D"_blank">jasonmckinley@mac.com</a></span>

 </span></div>
</div>
</td>
</tr>
<tr>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<span style=3D"font-family:Courier New,monospace">=E2=80=A2</span></td>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<div>
<div style=3D"margin:0 0 0.3em 0"><span><span>Josh Klein</span>

 </span></div>
</div>
</td>
</tr>
<tr>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<span style=3D"font-family:Courier New,monospace">=E2=80=A2</span></td>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<div>
<div style=3D"margin:0 0 0.3em 0"><span><span>Daniel Horowitz</span>

 </span></div>
</div>
</td>
</tr>
<tr>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<span style=3D"font-family:Courier New,monospace">=E2=80=A2</span></td>
<td style=3D"padding-right:10px;font-family:Arial,Sans-serif;font-size:13px=
;color:#222">
<div>
<div style=3D"margin:0 0 0.3em 0"><span><span>Keith Watson</span>

 </span></div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<div style=3D"padding-bottom:15px;font-family:Arial,Sans-serif;font-size:13=
px;color:#222;white-space:pre-wrap!important;white-space:pre-wrap;word-wrap=
:break-word">
<span>Rafe Furst is inviting you to a scheduled Zoom meeting.
<div><br>
</div>
<p>Join Zoom Meeting</p>
<p><a href=3D"https://www.google.com/url?q=3Dhttps%3A%2F%2Fzoom.us%2Fj%2F59=
11291378&amp;sa=3DD&amp;ust=3D1586371417733000&amp;usg=3DAFQjCNFvCUIrfLIlT9=
wxy1xrMlzvUSEDEg" target=3D"_blank">https://zoom.us/j/5911291378</a></p>
<div><br>
</div>
<p>Meeting ID: 591 129 1378</p>
<div><br>
</div>
<p>One tap mobile</p>
<p>+13462487799,,5911291378# US (Houston)</p>
<p>+16699006833,,5911291378# US (San Jose)</p>
<div><br>
</div>
<p>Dial by your location</p>
<p>+1 346 248 7799 US (Houston)</p>
<p>+1 669 900 6833 US (San Jose)</p>
<p>+1 312 626 6799 US (Chicago)</p>
<p>+1 929 436 2866 US (New York)</p>
<p>+1 253 215 8782 US</p>
<p>+1 301 715 8592 US</p>
<p>Meeting ID: 591 129 1378</p>
<p>Find your local number: <a href=3D"https://www.google.com/url?q=3Dhttps%=
3A%2F%2Fzoom.us%2Fu%2FabnmCquRh7&amp;sa=3DD&amp;ust=3D1586371417734000&amp;=
usg=3DAFQjCNFlPY14TnV4rpDJtggEadWzjS9o8g" target=3D"_blank">
https://zoom.us/u/abnmCquRh7</a></p>
<p>=E2=80=89=E3=80=80 =E2=80=88=E2=80=88 =E2=80=88=E2=80=88=E2=80=89 =E2=80=
=88 =E2=80=88=E2=80=89 =E3=80=80=E2=80=89 <br>
</p>
</span>

</div>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</span></span></div>
</blockquote>
</div>
<br>
</div>
</div>
</div>

</div></div></div><div hspace=3D"streak-pt-mark" style=3D"max-height:1px"><=
img alt=3D"" style=3D"width:0px;max-height:0px;overflow:hidden" src=3D"http=
s://mailfoogae.appspot.com/t?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocont=
ent&amp;guid=3D772381a8-8f6a-4b34-8969-5c36cc13ebf8"><font color=3D"#ffffff=
" size=3D"1">=E1=90=A7</font></div>

--0000000000008a237205a2677978--